Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-011362

CVP, Chief Financial Officer sold 14,510 shares at $76.55 ($1,110,794)

  • CVP, Chief Financial Officer acquired 14,510 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-12-29 Exercise or conversion : show line 1 in the form 10b5-1 +14,510 $36.75 $533,243 33,758 D
2023-12-29 Sale : show line 2 in the form 10b5-1 −14,510 $76.55 $1,110,794 19,248 D
Open-market sales · 14,510 sh · avg $76.55 · $1,110,794

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-12-29 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −14,510 $36.75 2024-05-10 14,510 29,015 D
Loading xslF345X05/doc4.xml…